Abstract:Nano-ZnO, as a commonly used nanomaterial, has been found in drinking water, food, and medicine; therefore, it poses potential health risks via the digestion system. However, little is known about the toxicity of nano-ZnO on the human intestinal microbiome, which plays critical roles in human health. This study comprehensively investigated the impact of nano-ZnO on the human gut microbiome, metabolic functions, and resistome using an in vitro colon simulator. Nano-ZnO induced concentration-dependent decreases in the production of short-chain fatty acids (SCFAs). Metagenomic analysis revealed that nano-ZnO not only led to dose-dependent shifts in the composition and diversity of the gut microbiota but also changed the key functional pathways of the gut microbiome. Although the diversity of the gut microbiota basically recovered after stopping exposure to nano-ZnO, SCFAs still showed a concentration-dependent decrease. Furthermore, although a medium concentration of nano-ZnO (2.5 mg/L) reduced the abundance of many antibiotic resistance genes (ARGs) by inhibiting the growth of related host bacteria, a low concentration of nano-ZnO (0.1 mg/L) greatly enriched the abundance of tetracycline resistance genes. Our findings provide evidence that nano-ZnO can impact the diversity, metabolism, and functional pathways of the human gut microbiome, as well as the gut resistome, highlighting the potential health effects of nanoparticles.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.est.1c00573?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.est.1c00573</a>.Transmission electron microscopy (TEM) analysis (Text S1); culture medium formula of the gut microbiome (Text S2); determination of gut gases (Text S3); determination of short-chain fatty acids (SCFAs) (Text S4); shotgun metagenomic sequencing and bioinformatic analysis (Text S5); microbial community analysis (Text S6); gene family and pathway analysis (Text S7); online ARG analysis pipeline (ARGs-OAP) (Text S8); cooccurrence between ARG subtypes and microbial taxa (Text S9); gas sensor array and its properties (Table S5); experimental setup and time schedule of the in vitro colon simulation model (Figure S1); principal component analysis (PCA) of the gut gases (Figure S2); α diversity comparison in the species level (Figures S3 and S4); TEM images of nano-ZnO and bacteria (no nano-ZnO exposure and after exposure to 0.1 mg/L nano-ZnO) (Figure S5); boxplot of Bray–Curtis distances at the genus and species levels (Figure S6); gene family analysis of the gut microbiota (Figure S7); discriminatory functional pathways identified by using Lefse (Figure S8); species' contributions to the function pathways (Figure S9); relative abundance of major bacteria species (Figure S10); relative standard deviation of ARG abundance (Figure S11); broad-spectrum quantitative profile of the 319 ARG subtypes (Figure S12); ARG abundance percentage normalized (Figure S13); relative abundance variation of ARG types (Figure S14); relative abundance of bacterial genera related to ARG types (Figure S15); and Procrustes analysis depicting the correlation between the ARG content and bacterial community (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acs.est.1c00573/suppl_file/es1c00573_si_001.pdf">PDF</a>)Types of detected genes and primer sets for qPCR analysis (Table S1); data quality assessment table of metagenomic sequencing (Table S2); statistical table of the assembly results (Table S3); statistical table of gene prediction (Table S4); profile of the microbial community composition of 21 samples (Table S6); and ARGs host information revealed by cooccurrence between ARG subtypes and microbial taxa (Table S7) (<a class="ext-link" href="/doi/suppl/10.1021/acs.est.1c00573/suppl_file/es1c00573_si_002.xlsx">XLSX</a>)This article has not yet been cited by other publications.

Nano-Al2O3 particles affect gut microbiome and resistome in an in vitro simulator of the human colon microbial ecosystem

Toxicity Assessment of Nano-ZnO Exposure on the Human Intestinal Microbiome, Metabolic Functions, and Resistome Using an In Vitro Colon Simulator

Cytotoxicity of zinc oxide nanoparticles and silver nanoparticles in human epithelial colorectal adenocarcinoma cells

Effect of Nanomaterials on Gut Microbiota

Enhanced Uptake of Antibiotic Resistance Genes in the Presence of Nanoalumina.

[Effects of nano titanium dioxide on gut microbiota based on human digestive tract microecology simulation system in vitro]

Effects of Nano-Tio2 on Antibiotic Resistance Transfer Mediated by RP4 Plasmid

The Effects of Orally Administered Ag, TiO 2 and SiO 2 Nanoparticles on Gut Microbiota Composition and Colitis Induction in Mice

Effects Of Oral Exposure To Titanium Dioxide Nanoparticles On Gut Microbiota And Gut-Associated Metabolism In Vivo

Nano-metal Oxides Induce Antimicrobial Resistance Via Radical-Mediated Mutagenesis

Effects of Nano-Titanium Dioxide on the Horizontal Transfer of Antibiotic Resistance Genes in Microplastic Biofilms

Microbiote Shift in Sequencing Batch Reactors in Response to Antimicrobial ZnO Nanoparticles

Oral administration of silver nanomaterials affects the gut microbiota and metabolic profile altering the secretion of 5-HT in mice

Nanoalumina Promotes The Horizontal Transfer Of Multiresistance Genes Mediated By Plasmids Across Genera

Impact of food grade and nano-TiO2 particles on a human intestinal community

Response of the Intertidal Microbial Community Structure and Metabolic Profiles to Zinc Oxide Nanoparticle Exposure

Intestinal toxicity of micro- and nano-particles of foodborne titanium dioxide in juvenile mice: Disorders of gut microbiota-host co-metabolites and intestinal barrier damage

Prebiotic Protects Against Anatase Titanium Dioxide Nanoparticles-Induced Microbiota-Mediated Colonic Barrier Defects

Resistance of multidrug resistant Escherichia coli to environmental nanoscale TiO2 and ZnO

Titanium dioxide nanoparticles elicit lower direct inhibitory effect on human gut microbiota than silver nanoparticles.

Gut microbiome and plasma metabolome changes in rats after oral gavage of nanoparticles: sensitive indicators of possible adverse health effects